Rego M F N, Pinheiro G S, Metze K, Lorand-Metze I
Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal do Piauí, Teresina, PI, Brasil.
Braz J Med Biol Res. 2003 Mar;36(3):331-7. doi: 10.1590/s0100-879x2003000300007. Epub 2003 Mar 7.
Differences in age and sex distribution as well as FAB (French-American-British classification) types have been reported for acute leukemias in several countries. We studied the demographics and response to treatment of patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) between 1989 and 2000 in Teresina, Piau , and compared these results with reports from Brazil and other countries. Complete data concerning 345 patients (230 ALL, 115 AML) were reviewed. AML occurred predominantly in adults (77%), with a median age of 34 years, similar to that found in the southeast of Brazil but lower than the median age in the United States and Europe (52 years). FAB distribution was similar in children and adults and FAB-M2 was the most common type, as also found in Japan. The high frequency of FAB-M3 described in most Brazilian studies and for Hispanics in the United States was not observed. Overall survival for adults was 40%, similar to other studies in Brazil. A high mortality rate was observed during induction. No clinical or hematological parameter influenced survival in the Cox model. ALL presented the characteristic peak of incidence between 2-8 years. Most of the cases were CD10+ pre-B ALL. In 25%, abnormal expression of myeloid antigens was observed. Only 10% of the patients were older than 30 years. Overall survival was better for children. Age and leukocyte count were independent prognostic factors. These data demonstrate that, although there are regional peculiarities, the application of standardized treatments and good supportive care make it possible to achieve results observed in other countries for the same chemotherapy protocols.
在几个国家,急性白血病的年龄和性别分布差异以及法国-美国-英国(FAB)分型已被报道。我们研究了1989年至2000年期间皮奥伊州特雷西纳市急性髓系白血病(AML)和急性淋巴细胞白血病(ALL)患者的人口统计学特征及治疗反应,并将这些结果与巴西和其他国家的报道进行比较。回顾了345例患者(230例ALL,115例AML)的完整数据。AML主要发生在成年人中(77%),中位年龄为34岁,与巴西东南部的情况相似,但低于美国和欧洲的中位年龄(52岁)。儿童和成人的FAB分布相似,FAB-M2是最常见的类型,日本也有类似情况。未观察到大多数巴西研究及美国西班牙裔人群中描述的FAB-M3的高频率。成人的总生存率为40%,与巴西的其他研究相似。诱导期观察到高死亡率。在Cox模型中,没有临床或血液学参数影响生存率。ALL在2至8岁之间呈现出特征性的发病高峰。大多数病例为CD10+前B-ALL。25%的病例观察到髓系抗原异常表达。只有10%的患者年龄超过30岁。儿童的总生存率更好。年龄和白细胞计数是独立的预后因素。这些数据表明,尽管存在地区特殊性,但标准化治疗的应用和良好的支持性护理使得采用相同化疗方案能够取得与其他国家观察到的结果。